Single-center Retrospective Study : Developmental Trajectories of Children Born Prematurely Before 32 Weeks Assessed With the Revised Brunet Lézine Scale at 1, 2 and 3 Years

December 9, 2024 updated by: Centre Hospitalier Intercommunal Creteil
This study will assess professionals in the CHI Créteil neonatal department and the Val de Marne perinatal network to gain a better understanding of the developmental trajectories of children hospitalized at the CHI Créteil, with a view to optimizing their care in the long term

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Créteil, France, 94000
        • Chi Creteil

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children born prematurely before 32 weeks

Description

Inclusion Criteria:

  • Children born at CHI Créteil between 2012 and 2022, included in the Val de Marne perinatal network.
  • Children seen in pediatrician-psychomotor consultation with assessment by the BLR scale at 1 year AC.

Exclusion Criteria:

  • Children born with a term of birth ≥ 32 weeks + 1 day.
  • Child removed from the Val de Marne perinatal network monitoring from the age of 1 year AC: Death or parental decision.
  • Children presenting with cerebral palsy, blindness or deafness at the age of 1 year AC.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Overall DQ obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.
Time Frame: 1, 2 and 3 years
1, 2 and 3 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Analysis of the 4 sub-scores (movement and posture, language, socialization, coordination) obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.
Time Frame: 1,2 and 3 years
1,2 and 3 years
Analysis of family socio-demographic data : level of education
Time Frame: 1,2 and 3 years
1,2 and 3 years
Analysis of family socio-demographic data : age of parents
Time Frame: 1,2 and 3 years
1,2 and 3 years
Analysis of birth data : term
Time Frame: 1, 2 and 3 years
1, 2 and 3 years
Analysis of birth data : weight
Time Frame: 1,2 and 3 years
1,2 and 3 years
Analysis of duration of hospitalization
Time Frame: 1,2 and 3 years
1,2 and 3 years
Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations
Time Frame: 5 years
5 years
Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations
Time Frame: 1,2 and 3 years
1,2 and 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 23, 2023

Primary Completion (Actual)

June 17, 2024

Study Completion (Actual)

June 17, 2024

Study Registration Dates

First Submitted

March 25, 2024

First Submitted That Met QC Criteria

December 9, 2024

First Posted (Estimated)

December 12, 2024

Study Record Updates

Last Update Posted (Estimated)

December 12, 2024

Last Update Submitted That Met QC Criteria

December 9, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth

Clinical Trials on Retrospective study

Subscribe